DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Oshima H, Miki T, Kuno A. et al
Empagliflozin, an SGLT-2 inhibitor, reduced the mortality rate after acute myocardial infarction with modification of cardiac metabolomes and antioxidants in diabetic rats.
J Pharmacol Exp Ther 2019;
368: 524-534 . doi:10.1124/jpet.118.253666
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.